Skip to main content

UPC Advisory

Uniform Practice Code Advisories are notices that pertain to unusual circumstances such as extremely large dividends, when-issued settlement dates, ex-interest dates for bonds, worthless securities, cancelled IPOs, etc. Their intent is to announce rulings, interpretations, exemptions and advisories on these subjects; to facilitate the transaction of a member's day-to-day business; and to eliminate business disputes and misunderstandings that may arise from uncertainty and lack of uniformity in such matters, The subjects addressed in the Uniform Practice Code Advisories are subject to the provisions of the FINRA Uniform Practice Code (Rule 11000 Series), which is administered by FINRA Operations.

Date UPC No. Title Format - Size
93-24 Pearl Diver Credit Company Inc (PDCPP) PDF - 89.03 KB
92-24 Pearl Diver Credit Company Inc (PDCPV)(When Issued) PDF - 96.22 KB
91-24 PG&E Corp (PCGEP) PDF - 88.58 KB
90-24 PG&E Corp (PCGEV) (When Issued) PDF - 95.94 KB
89-24 Aspen Insurance Holdings Ltd. (ASIHF) PDF - 88.56 KB
88-24 Aspen Insurance Holdings Ltd (ASIHV) (When Issued) PDF - 96.16 KB
87-24 Merchants Bancorp Inc. (MBIEL) PDF - 88.3 KB
86-24 Eletson Holdings Inc. PDF - 233.4 KB
85-24 Merchants Bancorp Inc. (MBIEV) (When Issued) PDF - 95.81 KB
84-24 SunPower Corporation PDF - 146.8 KB
83-24 SAS AB PDF - 148.65 KB
82-24 SVB Financial Group PDF - 173.01 KB
81-24 Sound Point Meridian Capital, Inc. (SPMCP) PDF - 87.92 KB
80-24 Sound Point Meridian Capital, Inc. (SPMCV) (When Issued) PDF - 96.54 KB
79-24 Boeing Company (BAAPL) PDF - 89.2 KB
78-24 Nextera Energy, Inc. (NEEXU) PDF - 88.56 KB
77-24 Nextera Energy, Inc. (NEECV) (When Issued) PDF - 95.9 KB
76-24 Boeing Company (BAAPV) (When Issued) PDF - 98.11 KB
75-24 Fisker, Inc. PDF - 152.83 KB
74-24 Shift Technologies, Inc. PDF - 152.82 KB
73-24 Eagle Point Institutional Income Fund (EGLPP) PDF - 87.15 KB
72-24 Airspan Networks Holdings Inc. PDF - 173.11 KB
71-24 Eagle Point Institutional Income Fund (EGLPV) (When Issued) PDF - 96.52 KB
70-24 Eiger Biopharmaceuticals, Inc PDF - 147.09 KB
69-24 PhaseBio Pharmaceuticals, Inc PDF - 143.83 KB